Report Summary

Alizyme plc (LON:AZM) Financial and Strategic Analysis Review

Alizyme plc is a specialty biopharmaceutical development company that primarily focuses on the therapeutic areas of metabolic disorders, gastrointestinal disorders and cancer supportive care. It is engaged in developing products for the treatment and management of obesity and related conditions, such as type 2 diabetes, of gastrointestinal disorders involving inflammation, such as ulcerative colitis, and of the gastrointestinal side effects of cancer therapy, such as mucositis. Its products in development include Cetilistat for the treatment of obesity and associated conditions, COLAL-PRED for the treatment of ulcerative colitis and ATL-104 for mucositis.

The Alizyme plc - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Alizyme plc. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

- Provides key company information for business intelligence needs.
- The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

- A quick "one-stop-shop" to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Capitalize on competitor's weaknesses and target the market opportunities available to them.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.